Search company, investor...
Search

Founded Year

2016

Stage

Biz Plan Competition - II | Alive

Total Raised

$2.74M

About Retinai

Retinai supports eye care professionals and patients throughout the medical examination process using Artificial Intelligence. Its vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as age-related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. Its solutions rely on advances in medical image analysis, opthalmology, and machine learning.

Retinai Headquarters Location

3 Freiurgstrasse

Bern, 3010,

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Retinai's Products & Differentiation

See Retinai's products and how their products differentiate from alternatives and competitors

  • RetinAI Discovery

    RetinAI Discovery® is a CE-Marked medical image and data management platform with certified AI Models to aggregate data an extracting automatic insights on patient diseases and outcomes. The platform can be configured to connect to PACS or integrate via API calls with the clinic systems. Ophthalmologists in this setting have a single platform that is secure, cloud-based and provides real-time data access. The platform enables participative research and management. Users of the platform can easily share cases with other users granted access, anytime from anywhere.

    Differentiation

    Fully certified data management platform with certified AI solutions in ophthalmology tailored for clinical trials and eye clinics. 

    Variety of image modalities and formats (imaging, data, genetic information, biomarkers, ...) 

Expert Collections containing Retinai

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Retinai is included in 6 Expert Collections, including Digital Health.

D

Digital Health

21,952 items

Startups recreating how healthcare is delivered

A

Artificial Intelligence

9,391 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,490 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Diabetes

1,750 items

H

Health IT

7,901 items

Retinai Patents

Retinai has filed 2 patents.

The 3 most popular patent topics include:

  • Computer vision
  • Feature detection (computer vision)
  • Image processing
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/16/2018

11/9/2021

Image processing, Artificial neural networks, Computer vision, Medical imaging, Feature detection (computer vision)

Grant

Application Date

5/16/2018

Grant Date

11/9/2021

Title

Related Topics

Image processing, Artificial neural networks, Computer vision, Medical imaging, Feature detection (computer vision)

Status

Grant

Latest Retinai News

RetinAI Discovery achieves FDA clearance

May 2, 2022

RetinAI Medical AG received the U.S. Food and Drug Administration 510(k) clearance of RetinAI Discovery, paving the way for the startup to enter the U.S market. The image and data management platform enables next-level interoperability across the clinical and clinical study ecosystems in ophthalmology.

Retinai Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Retinai Rank

  • When was Retinai founded?

    Retinai was founded in 2016.

  • Where is Retinai's headquarters?

    Retinai's headquarters is located at 3 Freiurgstrasse, Bern.

  • What is Retinai's latest funding round?

    Retinai's latest funding round is Biz Plan Competition - II.

  • How much did Retinai raise?

    Retinai raised a total of $2.74M.

  • Who are the investors of Retinai?

    Investors of Retinai include IMD Startup Competition, btov Partners, investiere, Eurostars Programme and Venture Kick.

  • Who are Retinai's competitors?

    Competitors of Retinai include Eyenuk and 7 more.

  • What products does Retinai offer?

    Retinai's products include RetinAI Discovery.

  • Who are Retinai's customers?

    Customers of Retinai include Novartis.

You May Also Like

Eyenuk Logo
Eyenuk

Eyenuk is focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and preserving their vision. Using computer vision and image analysis expertise, the company is developing a portfolio of products based on its proprietary retinal image analysis technology to identify and track the progression of eye diseases including diabetic retinopathy and age-related macular degeneration. The company was founded in 2010 and is based in Woodland Hills, California.

Digital Diagnostics Logo
Digital Diagnostics

Digital Diagnostics is an AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The platform includes two autonomous AI systems, IDx-DR and 3DermSpot. The company was founded in 2010 and is based in Coralville, Iowa.

V
Viderai

Viderai provides retinal analysis using artificial intelligence to patients. It offers products that help specialists diagnose patients with diseases such as diabetic retinopathy. Its primary clients are ophthalmologists and public healthcare insurance companies. Viderai was founded in 2019 and is based in Ostrava, the Czech Republic.

Remidio Logo
Remidio

Remidio is an ophthalmic products company that offers products at affordable prices. The company's vision is to bring to market ophthalmic devices that are affordable, easy-to-use, and built with a larger aim of tackling avoidable blindness in resource-starved situations.

o
ocumeda

ocumeda offers low-threshold eye examinations in cooperation with opticians, retirement homes, and companies. It specializes in cloud platforms as well as developing medical AI products that prevent blindness and vision impairment. The company operates in the healthcare sector. It was founded in 2019 and is based in Erlen, Switzerland.

Binah.ai Logo
Binah.ai

Binah.ai is the developer of a real-time vital signs measurement app that only requires a smartphone, laptop, or tablet camera. Its app supports iOS devices, Android mobile devices, and Windows laptops and desktops.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.